US Stock MarketDetailed Quotes

Oruka Therapeutics (ORKA)

Watchlist

68.920
+1.850+2.76%

Close Apr 17 16:00 ET

72.987
+4.067+5.90%

Post 20:01 ET

3.41BMarket Cap-37.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oruka Therapeutics (ORKA) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-88.21M

-22.59M

-21.6M

-109.78%-23.15M

-12,322.02%-20.87M

-11.03M

-168K

Net income from continuing operations

---105.43M

---29.58M

---30.28M

-10.48%-24.57M

-196.72%-21M

---22.24M

---7.08M

Depreciation and amortization

--83K

--28K

--20K

--19K

--16K

--0

Other non cash items

---4.55M

---524K

---908K

-23,066.67%-1.38M

-173,600.00%-1.74M

--6K

--1K

Change In working capital

---2.56M

--3.37M

---602K

-121.76%-2.29M

-144.47%-3.03M

--10.52M

--6.82M

-Change in receivables

----

--0

--1K

-Change in prepaid assets

---3.97M

---805K

---2.4M

64.15%-617K

---148K

---1.72M

--0

-Change in payables and accrued expense

--1.93M

--4.16M

--2.24M

-113.55%-1.66M

-141.12%-2.81M

--12.28M

--6.82M

-Change in other current assets

---60K

--0

---60K

---43K

--0

-Change in other current liabilities

---448K

--20K

---439K

-300.00%-8K

---21K

--4K

--0

Cash from discontinued investing activities

Operating cash flow

---88.21M

---22.59M

---21.6M

-109.78%-23.15M

-12,322.02%-20.87M

---11.03M

---168K

Investing cash flow

Cash flow from continuing investing activities

-96.75M

-22.02M

-122.45M

4.86M

42.87M

Net PPE purchase and sale

---209K

---63K

---99K

---34K

---13K

--0

Net investment purchase and sale

---96.54M

---21.96M

---122.35M

--4.89M

--42.88M

--0

Cash from discontinued investing activities

Investing cash flow

---96.75M

---22.02M

---122.45M

--4.86M

--42.87M

--0

Financing cash flow

Cash flow from continuing financing activities

170.32M

298K

169.91M

106.86%109K

-1.59M

27.91M

Net issuance payments of debt

--0

--24.98M

Net common stock issuance

--671K

--562K

--0

----

Net preferred stock issuance

--0

--2.93M

Net other financing activities

--169.64M

---264K

----

Cash from discontinued financing activities

Financing cash flow

--170.32M

--298K

--169.91M

106.86%109K

--0

---1.59M

--27.91M

Net cash flow

Beginning cash position

--61.58M

--91.25M

--65.4M

201.24%83.57M

--61.58M

--27.74M

--0

Current changes in cash

---14.64M

---44.32M

--25.86M

-44.00%-18.18M

-20.71%22M

---12.62M

--27.74M

End cash Position

--46.94M

--91.25M

332.48%65.4M

201.24%83.57M

--15.12M

--27.74M

Free cash flow

---88.42M

---22.66M

---21.7M

-110.09%-23.18M

-12,329.76%-20.88M

---11.03M

---168K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-88.21M	-22.59M	-21.6M	-109.78%-23.15M	-12,322.02%-20.87M	-11.03M	-168K
Net income from continuing operations	---105.43M	---29.58M	---30.28M	-10.48%-24.57M	-196.72%-21M	---22.24M	---7.08M
Depreciation and amortization	--83K	--28K	--20K	--19K	--16K	--0	--0
Other non cash items	---4.55M	---524K	---908K	-23,066.67%-1.38M	-173,600.00%-1.74M	--6K	--1K
Change In working capital	---2.56M	--3.37M	---602K	-121.76%-2.29M	-144.47%-3.03M	--10.52M	--6.82M
-Change in receivables	----	----	----	--0	--0	--0	--1K
-Change in prepaid assets	---3.97M	---805K	---2.4M	64.15%-617K	---148K	---1.72M	--0
-Change in payables and accrued expense	--1.93M	--4.16M	--2.24M	-113.55%-1.66M	-141.12%-2.81M	--12.28M	--6.82M
-Change in other current assets	---60K	--0	--0	--0	---60K	---43K	--0
-Change in other current liabilities	---448K	--20K	---439K	-300.00%-8K	---21K	--4K	--0
Cash from discontinued investing activities
Operating cash flow	---88.21M	---22.59M	---21.6M	-109.78%-23.15M	-12,322.02%-20.87M	---11.03M	---168K
Investing cash flow
Cash flow from continuing investing activities	-96.75M	-22.02M	-122.45M	4.86M	42.87M	0	0
Net PPE purchase and sale	---209K	---63K	---99K	---34K	---13K	--0	--0
Net investment purchase and sale	---96.54M	---21.96M	---122.35M	--4.89M	--42.88M	--0	--0
Cash from discontinued investing activities
Investing cash flow	---96.75M	---22.02M	---122.45M	--4.86M	--42.87M	--0	--0
Financing cash flow
Cash flow from continuing financing activities	170.32M	298K	169.91M	106.86%109K	0	-1.59M	27.91M
Net issuance payments of debt	--0	--0	--0	--0	--0	--0	--24.98M
Net common stock issuance	--671K	--562K	--0	----	----	----	----
Net preferred stock issuance	--0	--0	--0	--0	--0	--0	--2.93M
Net other financing activities	--169.64M	---264K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--170.32M	--298K	--169.91M	106.86%109K	--0	---1.59M	--27.91M
Net cash flow
Beginning cash position	--61.58M	--91.25M	--65.4M	201.24%83.57M	--61.58M	--27.74M	--0
Current changes in cash	---14.64M	---44.32M	--25.86M	-44.00%-18.18M	-20.71%22M	---12.62M	--27.74M
End cash Position	--46.94M	--46.94M	--91.25M	332.48%65.4M	201.24%83.57M	--15.12M	--27.74M
Free cash flow	---88.42M	---22.66M	---21.7M	-110.09%-23.18M	-12,329.76%-20.88M	---11.03M	---168K
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm